April 23, 2009
Herscu Laboratory has launched a separate website on influenza, providing updates, tools, and other resources related to the current H1N1 flu epidemic, influenza in general, and CAM treatment in influenza. The website can be viewed at www.hersculaboratoryflu.org.
April 22, 2009
Submitted "Study of Angiotensin Converting Enzyme Inhibitor-induced Angioedema in a Community Hospital Emergency Department" to Annals of Allergy, Asthma, and Immunology. This paper reports the results of a retrospective review examining the clinical course and presentation of ACE-I induced angioedema patients.
April 20, 2009
Submitted "Clinical Prediction Rules: New Opportunities for Pharma" to the journal Drug Discovery Today. The paper presents a brief summary of the progress and potential of clinical prediction tools, and discusses their application in the pharmaceutical industry, particularly with regards to personalized medicine and phenomics.
April 10, 2009
Submitted "Methodological Considerations for Controlled Influenza Treatment Studies in CAM" to the Journal of Complementary and Alternative Medicine. This article reviews and summarizes the standard design elements in influenza antiviral studies, and suggests they be mirrored in future CAM studies on influenza.
March 10, 2009
Submitted "Homeopathic Trial Design in Influenza Treatment", a review looking at design methodology in controlled homeopathic influenza studies, to Homeopathy.
February 15, 2009
Submitted "Angiotensin Converting Inhibitor Induced Angioedema: A review of the research basis for a clinical prediction guide" to Clinical and Experimental Allergy. This paper presents a review of the genetics, metabolomics, and proteomics of ACE-I angioedema, and then illustrates the research basis for phenomical markers and risk factors for use in creating a clinical prediction tool to help differentiate angioedema causes.
March 15, 2008
Partnered with Personalized Pharmaceutical Solutions (PPS) to begin work on ACE-I and other pharmaceutical research. See more info in the Pharmaceutical research section.
Partnered with The Helfgott Research Institute to begin clinical study on influenza treatment with homeopathy. See more info in the CAM research section.